Evidence map›Paper›PMID 36769493›Full record

ArticleJournal of clinical medicine2023

Application of Nonlinear Models Combined with Conventional Laboratory Indicators for the Diagnosis and Differential Diagnosis of Ovarian Cancer.

Tongshuo Zhang, Aibo Pang, Jungang Lyu, Hefei Ren, Jiangnan Song, Feng Zhu, Jinlong Liu, Yuntao Cui, Cunbao Ling, Yaping Tian

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. [Medical prior-guided TabMap deep learning model for ovarian cancer prediction and interpretability analysis].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tongshuo ZhangDepartment of Laboratory Medicine and Pathology, Jiangsu Provincial Corps Hospital of Chinese People's Armed Police Force (PAP), Yangzhou 225003, China.ORCID 0000-0003-2277-4501
Aibo PangCenter for Birth Defects Prevention and Control Technology Research, Chinese PLA General Hospital, Beijing 100853, China.ORCID 0000-0002-3500-0057
Jungang LyuThird Department of Internal Medicine, Beijing Corps Hospital of PAP, Beijing 100027, China.ORCID 0000-0002-2704-0331
Hefei RenDepartment of Laboratory Medicine, The Second Affiliated Hospital, Naval Medical University, Shanghai 200003, China.ORCID 0000-0003-0946-5683
Jiangnan SongDepartment of Obstetrics and Gynecology, The First Medical Centre, Chinese PLA General Hospital, Beijing 100853, China.ORCID 0000-0003-3872-2263
Feng ZhuDepartment of Laboratory Medicine and Pathology, Jiangsu Provincial Corps Hospital of Chinese People's Armed Police Force (PAP), Yangzhou 225003, China.ORCID 0000-0002-7883-0245
Jinlong LiuDepartment of Obstetrics and Gynecology, The 79th Group Army Hospital of PLA, Liaoyang 111000, China.ORCID 0000-0002-1554-2000
Yuntao CuiDepartment of Laboratory Medicine, Characteristic Medical Center of PAP, Tianjin 300162, China.
Cunbao LingCenter for Birth Defects Prevention and Control Technology Research, Chinese PLA General Hospital, Beijing 100853, China.ORCID 0000-0002-5851-8780
Yaping TianCenter for Birth Defects Prevention and Control Technology Research, Chinese PLA General Hospital, Beijing 100853, China.

Funding

Key Project "Proactive health and aging technology responses" of the National Key Research and Development Project of China 2021Yfc2009300
6 · The paper itself

Abstract

Existing biomarkers for ovarian cancer lack sensitivity and specificity. We compared the diagnostic efficacy of nonlinear machine learning and linear statistical models for diagnosing ovarian cancer using a combination of conventional laboratory indicators. We divided 901 retrospective samples into an ovarian cancer group and a control group, comprising non-ovarian malignant gynecological tumor (NOMGT), benign gynecological disease (BGD), and healthy control subgroups. Cases were randomly assigned to training and internal validation sets. Two linear (logistic regression (LR) and Fisher's linear discriminant (FLD)) and three nonlinear models (support vector machine (SVM), random forest (RF), and artificial neural network (ANN)) were constructed using 22 conventional laboratory indicators and three demographic characteristics. Model performance was compared. In an independent prospectively recruited validation set, the order of diagnostic efficiency was RF, SVM, ANN, FLD, LR, and carbohydrate antigen 125 (CA125)-only (AUC, accuracy: 0.989, 95.6%; 0.985, 94.4%; 0.974, 93.4%; 0.915, 82.1%; 0.859, 80.1%; and 0.732, 73.0%, respectively). RF maintained satisfactory classification performance for identifying different ovarian cancer stages and for discriminating it from NOMGT-, BGD-, or CA125-positive control. Nonlinear models outperformed linear models, indicating that nonlinear machine learning models can efficiently use conventional laboratory indicators for ovarian cancer diagnosis.

Indexed as

laboratory diagnosismachine learningmultiple indicator combinationsnonlinear modelovarian cancer

Identifiers

PMID36769493
PMCPMC9917843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.